Literature DB >> 11435571

Characterization of a late entry event in the replication cycle of human immunodeficiency virus type 2.

D J Griffiths, M Dittmar, P Clapham, E Thomas.   

Abstract

Certain human cell lines and primary macrophage cultures are restricted to infection by some primary isolates of human immunodeficiency virus type 2 (HIV-2), although early steps of the viral life cycle such as fusion at the plasma membrane and reverse transcription are fully supported. The late postintegration events, transcription, translation, assembly, budding, and maturation into infectious virions are functional in restrictive cells. Apart from primary macrophages, the restrictive cell types are actively dividing, and nuclear import of preintegration complexes (PICs) is not required for infection. We therefore postulate that the PICs are trapped in a cellular compartment, preventing subsequent steps in the replication cycle that lead to integration of the provirus. To test this we showed that HIV-2 particles pseudotyped with vesicular stomatitis virus envelope G protein, which delivers HIV into an endocytic compartment, could overcome the block to infection. We suggest that delivery of the viral core into an appropriate cellular compartment is a critical step during the entry process of HIV.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435571      PMCID: PMC114419          DOI: 10.1128/JVI.75.15.6914-6922.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  Evidence for a newly discovered cellular anti-HIV-1 phenotype.

Authors:  J H Simon; N C Gaddis; R A Fouchier; M H Malim
Journal:  Nat Med       Date:  1998-12       Impact factor: 53.440

3.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

4.  Fv-1 host cell restriction of friend leukemia virus: microinjection of unintegrated viral DNA.

Authors:  J Chinsky; R Soeiro; J Kopchick
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

Review 5.  Nuclear import of human immunodeficiency virus type-1 preintegration complexes.

Authors:  R A Fouchier; M H Malim
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

6.  Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes.

Authors:  Y D Korin; J A Zack
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Integration is not necessary for expression of human immunodeficiency virus type 1 protein products.

Authors:  M Stevenson; S Haggerty; C A Lamonica; C M Meier; S K Welch; A J Wasiak
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure.

Authors:  J A Zack; S J Arrigo; S R Weitsman; A S Go; A Haislip; I S Chen
Journal:  Cell       Date:  1990-04-20       Impact factor: 41.582

9.  Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.

Authors:  N A Kootstra; H Schuitemaker
Journal:  Virology       Date:  1999-01-20       Impact factor: 3.616

10.  Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes.

Authors:  D S Friend; D Papahadjopoulos; R J Debs
Journal:  Biochim Biophys Acta       Date:  1996-01-12
View more
  14 in total

1.  An envelope-determined, pH-independent endocytic route of viral entry determines the susceptibility of human immunodeficiency virus type 1 (HIV-1) and HIV-2 to Lv2 restriction.

Authors:  David Marchant; Stuart J D Neil; Keith Aubin; Christian Schmitz; Aine McKnight
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

2.  Metabolic profiling during HIV-1 and HIV-2 infection of primary human monocyte-derived macrophages.

Authors:  Joseph A Hollenbaugh; Catherine Montero; Raymond F Schinazi; Joshua Munger; Baek Kim
Journal:  Virology       Date:  2016-02-16       Impact factor: 3.616

3.  A TRIM5alpha-independent post-entry restriction to HIV-1 infection of macaque cells that is dependent on the path of entry.

Authors:  Mario Javier Pineda; Brannon R Orton; Julie Overbaugh
Journal:  Virology       Date:  2007-03-09       Impact factor: 3.616

4.  Characterization of producer cell-dependent restriction of murine leukemia virus replication.

Authors:  Fatima Serhan; Nathalie Jourdan; Sylvie Saleun; Philippe Moullier; Ghislaine Duisit
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

5.  Lv2, a novel postentry restriction, is mediated by both capsid and envelope.

Authors:  Christian Schmitz; David Marchant; Stuart J D Neil; Keith Aubin; Sandra Reuter; Matthias T Dittmar; Aine McKnight
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

6.  Early detection of a two-long-terminal-repeat junction molecule in the cytoplasm of recombinant murine leukemia virus-infected cells.

Authors:  Fatima Serhan; Magalie Penaud; Caroline Petit; Thierry Leste-Lasserre; Stéphane Trajcevski; David Klatzmann; Ghislaine Duisit; Pierre Sonigo; Philippe Moullier
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.

Authors:  Kelly M Marno; Rebecca Pike; Joseph M Gibbons; Wing-Yiu Jason Lee; Christopher E Jones; Babatunji W Ogunkolade; Claire Pardieu; Alexander Bryan; Rebecca Menhua Fu; Gary Warnes; Paul A Rowley; Richard D Sloan; Áine McKnight
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

8.  A whole genome screen for HIV restriction factors.

Authors:  Li Liu; Nidia M M Oliveira; Kelly M Cheney; Corinna Pade; Hanna Dreja; Ann-Marie H Bergin; Viola Borgdorff; David H Beach; Cleo L Bishop; Matthias T Dittmar; Aine McKnight
Journal:  Retrovirology       Date:  2011-11-14       Impact factor: 4.602

9.  Human TRIM5alpha mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants.

Authors:  Patrick Kaumanns; Isabel Hagmann; Matthias T Dittmar
Journal:  Retrovirology       Date:  2006-11-06       Impact factor: 4.602

Review 10.  Early steps of retrovirus replicative cycle.

Authors:  Sébastien Nisole; Ali Saïb
Journal:  Retrovirology       Date:  2004-05-14       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.